Prevalence and Clinical Significance of CSF Alzheimer's Disease Biomarkers in People With Versus Without HIV
Johns Hopkins Medicine via YouTube
Master Production-Ready Machine Learning, Step by Step
Power BI Fundamentals - Create visualizations and dashboards from scratch
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
This seminar explores the prevalence and clinical significance of cerebrospinal fluid (CSF) Alzheimer's disease biomarkers in people with versus without HIV. Presented by Dr. Erin Sundermann and Lilly Ham from the University of California, San Diego, the 51-minute talk delves into the intersection of HIV and Alzheimer's disease research. Learn about how these biomarkers differ between HIV-positive and HIV-negative individuals, and understand their implications for diagnosis, treatment, and long-term care. The presentation is part of the Johns Hopkins Medicine seminar series focused on neuroHIV research, providing valuable insights for healthcare professionals, researchers, and those interested in the neurological complications of HIV infection.
Syllabus
Prevalence and Clinical Significance of CSF Alzheimer's Disease Biomarkers
Taught by
Johns Hopkins Medicine